Inovio Pharmaceuticals, Inc (INO) insider trading
Every open-market stock purchase and sale by Inovio Pharmaceuticals, Inc executives, directors, large shareholders and members of Congress, from SEC Form 4 filings. Sector: Other.
Insider activity at a glance
- No open-market insider trades in the last 12 months.
- Last insider buy: Jong Joseph Kim (CEO), $70K, 6 years ago.
Last 12 months: insiders bought $0 (0 buys) and sold $0 (0 sales). Last close $0.80 on Oct 21, 2026.
Recent INO insider trades
| Date | Insider | Trade | Value |
|---|---|---|---|
| May 20, 2026 | Jacqueline Elizabeth Shea (CEO) | Sold (not open market) | $15.1K |
| May 20, 2026 | Peter Kies (CFO) | Sold (not open market) | $5.8K |
| May 20, 2026 | Michael John Sumner (C-suite exec) | Sold (not open market) | $3.3K |
| May 20, 2026 | Laurent Humeau (C-suite exec) | Sold (not open market) | $2.7K |
| May 20, 2026 | Roger D Dansey (Director) | Bought (not open market) | — |
| May 20, 2026 | Wendy L Yarno (Director) | Bought (not open market) | — |
| May 20, 2026 | Wendy L Yarno (Director) | Bought (not open market) | — |
| May 20, 2026 | Lota S. Zoth (Director) | Bought (not open market) | — |
| May 20, 2026 | Lota S. Zoth (Director) | Bought (not open market) | — |
| May 20, 2026 | Jay Shepard (Director) | Bought (not open market) | — |
| May 20, 2026 | Jay Shepard (Director) | Bought (not open market) | — |
| May 20, 2026 | David B. Weiner (Director) | Bought (not open market) | — |
| May 20, 2026 | David B. Weiner (Director) | Bought (not open market) | — |
| May 20, 2026 | Laurent Humeau (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Laurent Humeau (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Laurent Humeau (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Ann Calby Miller (Director) | Bought (not open market) | — |
| May 20, 2026 | Ann Calby Miller (Director) | Bought (not open market) | — |
| May 20, 2026 | Jacqueline Elizabeth Shea (CEO) | Bought (not open market) | — |
| May 20, 2026 | Jacqueline Elizabeth Shea (CEO) | Bought (not open market) | — |
| May 20, 2026 | Michael John Sumner (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Michael John Sumner (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Jacqueline Elizabeth Shea (CEO) | Bought (not open market) | — |
| May 20, 2026 | Michael John Sumner (C-suite exec) | Bought (not open market) | — |
| May 20, 2026 | Peter Kies (CFO) | Bought (not open market) | — |
Who's trading INO
- Simon X Benito, Director: other filings, last May 20, 2026
- Roger D Dansey, Director: other filings, last May 20, 2026
- Laurent Humeau, C-suite exec: other filings, last May 20, 2026
- Peter Kies, CFO: other filings, last May 20, 2026
- Ann Calby Miller, Director: other filings, last May 20, 2026
- Jacqueline Elizabeth Shea, CEO: other filings, last May 20, 2026
- Jay Shepard, Director: other filings, last May 20, 2026
- Michael John Sumner, C-suite exec: other filings, last May 20, 2026
- David B. Weiner, Director: other filings, last May 20, 2026
- Wendy L Yarno, Director: other filings, last May 20, 2026
- Lota S. Zoth, Director: other filings, last May 20, 2026
Get free alerts when an insider at Inovio Pharmaceuticals, Inc files a new trade →